Scarica l'app Stockscreener
1.31
6.50%
0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PACB Giù?
Forum
Previsione
Pacific Biosciences Of California Inc Borsa (PACB) Ultime notizie
Published on: 2025-08-15 04:22:23 - thegnnews.com
PacBio (PACB) Shares Skyrocket, What You Need To Know - Yahoo Finance
PacBio’s Path: Upward Surge or Shortlived Spike? - StocksToTrade
Pacific Biosciences Of California, Inc. shares rise 1.65% premarket. - AInvest
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q2 2025 Earnings Call Transcript - Insider Monkey
The Analyst Verdict: Pacific Biosciences In The Eyes Of 4 Experts - 富途牛牛
PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results - FinancialContent
PACB Analyst Update: Piper Sandler Raises Price Target by 20% | - GuruFocus
Pacific Biosciences: Piper Sandler Keeps Neutral Rating, Raises PT to $1.5 - AInvest
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - 富途牛牛
Pacific Biosciences of California Earnings: Analysts Boost Forecasts for 2025 - AInvest
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - uk.finance.yahoo.com
Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates - MSN
Pacific Biosciences Q2 2025 Revenue Surpasses Analyst Estimate at $39.8 Million, GAAP Net Loss Narrows to $0.14 - AInvest
PacBio Reports Q2 EPS, Revenue Growth, and Positive Cash Flow - AInvest
Pacific Biosciences Receives Buy Rating from Bernstein, Maintains $1.70 Price Target - AInvest
Pacific Biosciences shares rise 3.57% intraday after reporting smaller-than-expected Q2 loss and positive trial data. - AInvest
PacBio (PACB) Stock Trades Up, Here Is Why - Yahoo Finance
Bernstein Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Raises Target Price to $1.7 - 富途牛牛
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises - Yahoo Finance
Pacific Biosciences stock price target raised by Bernstein to $1.70 on clinical uptake - Investing.com Canada
Powered by PacBio: Selected publications from July 2025 - PacBio
Earnings call transcript: Pacific Biosciences Q2 2025 beats revenue expectations, stock surges - Investing.com Canada
Pacific Biosciences: Q2 Earnings Snapshot - Connecticut Post
Pacific Biosciences of California Q2 2025 Earnings Call Transcript - MarketBeat
Pacific Biosciences shares rise 11.11% premarket after reporting smaller-than-expected Q2 loss and positive trial data. - AInvest
PacBio Narrowed Losses As New Tech And China Deal Paid Off - Finimize
Pacific Biosciences of California Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars - TradingView
Pacific Biosciences Q2 Earnings: Smaller Loss Than Expected - AInvest
PacBio Announces Second Quarter 2025 Financial Results - GlobeNewswire
Pacific Biosciences Q2 Earnings Exceed Expectations with $39.8M Revenue and -$0.13 Non-GAAP EPS - AInvest
PacBio to Present at Upcoming Investor Conferences - 富途牛牛
PacBio to Present at Upcoming Investor Conferences in August and September 2025 - Quiver Quantitative
PacBio (PACB) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
Pacific Biosciences of California Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Will Pacific Biosciences of California Inc. Reverse From Oversold ConditionsChart Driven High Reward Trading Setup Presented - beatles.ru
Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
PacBio and Collaborators Release Landmark Platinum Pedigree Dataset, Enhancing Genomic Variant Accuracy by 34% With AI Integration - Quiver Quantitative
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models - Yahoo Finance
How strong is Pacific Biosciences of California Inc. company’s balance sheetGet expert advice on portfolio optimization - Jammu Links News
When is Pacific Biosciences of California Inc. stock expected to show significant growthOutstanding capital returns - Jammu Links News
What catalysts could drive Pacific Biosciences of California Inc. stock higher in 2025Invest smarter with expert trading signals - Jammu Links News
Should I hold or sell Pacific Biosciences of California Inc. stock in 2025Superior risk-adjusted returns - Jammu Links News
How does Pacific Biosciences of California Inc. generate profit in a changing economyAchieve rapid wealth accumulation with smart picks - Jammu Links News
What institutional investors are buying Pacific Biosciences of California Inc. stockUnprecedented profits - Jammu Links News
What are Pacific Biosciences of California Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - Jammu Links News
What is Pacific Biosciences of California Inc. company’s growth strategyExponential return rates - Jammu Links News
Is Pacific Biosciences of California Inc. a growth stock or a value stockAccess high-yield investment alerts now - Jammu Links News
What are analysts’ price targets for Pacific Biosciences of California Inc. in the next 12 monthsLightning-fast growth - Jammu Links News
1.74%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):